Galectin Therapeutics Inc. (GALT)

[Darwinian]

It's easy to see already where AF is going to pick to hit us on this.

I'm looking forward to hearing more detailed info. Don't get me wrong, I think these are good results, I'm just left with several questions.

1. No mention of FibroScan
2. No mention of biopsy in phase 2. It says "and the amount of collagen, as determined by digital morphometric analysis, as a key secondary endpoint" Does anyone know what this is? I'm guessing it's a Fibroscan type of analysis, but I really don't know. Is there a Dr. in the house?
3. 4 patients still need to complete their treatment before the trial ends. (not really a question)

I guess this isn't the final report from the cohort. A little more patience is required...

It'll be interesting to see how the market reacts. I hope it is good. I doubled my warrants last week.

–D